Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update

References

• Baba PDI, Lewis LH, Neeraj K, et al. Sickle cell disease—genetics, pathophysiology, clinical presentation and treatment. Int J Neonatal Screen. 2019;5(2):20. DOI:10.3390/ijns5020020.
   PubMed Web of Science ®Google Scholar
• Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376:1561–1573. DOI:10.1056/NEJMra1510865.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115:4331–4336. DOI:10.1182/blood-2010-01-251348.
   PubMed Web of Science ®Google Scholar
• Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates. Lancet. 2013;381:142–151. DOI: 10.1016/S0140-6736(12)61229-X.
   PubMed Web of Science ®Google Scholar
• Mengnjo MK, Kamtchum-Tatuene J, Nicastro N, et al. Complications of sickle cell disease in Africa: protocol for a systematic review. Br Med J. 2016;6:e012981. DOI:10.1136/bmjopen-2016-012981.
   PubMedGoogle Scholar
• Kasai ET, Opara JPA, Kadima JN, et al. Overview of current progress and challenges in diagnosis, and management of pediatric sickle cell disease in democratic republic of the Congo. Hematology. 2022;1:132–140. DOI:10.1080/16078454.2021.2023399.
   Google Scholar
• Lindenau JD, Wagner SC, Castro SM, et al. The effects of old and recent migration waves in the distribution of HBB* S globin gene haplotypes. Genet Mol Biol. 2016;39:515–523. DOI:10.1590/1678-4685-gmb-2016-0032.
   PubMed Web of Science ®Google Scholar
• Dokekias AE, Gokaba LTO, Louokdom JS, et al. Neonatal screening for sickle cell disease in Congo. Anemia. 2022;6:Article ID 9970315. DOI:10.1155/2022/9970315.
   Google Scholar
• Munyanganizi R, Cotton F, Vertongen F, et al. Red blood cell disorders in Rwandese neonates: screening for sickle cell disease and glucose-6-phosphate dehydrogenase deficiency. J Med Screen. 2006;13:129–131.
   PubMed Web of Science ®Google Scholar
• McGann PT, Ferris MG, Ramamurthy U, et al. A prospective newborn screening and treatment program for sickle cell anemia in Luanda. Angola Am J Hematol. 2013;88:984–989. DOI:10.1002/ajh.23578.
   PubMed Web of Science ®Google Scholar
• Abdala KA, Shindano ME, Mbongi D, et al. Dépistage hospitalier de la drépanocytose en République Démocratique du Congo (RDC) par HemoTypeSC: cas de la ville de Kindu. Pan African Med J. 2022;41:134. DOI:10.11604/pamj.2022.41.134.30187.
   PubMedGoogle Scholar
• Tebandite K, Muyobela K, Lusamaki M, et al. Effect of TB therapy on the health and nutritional status of infants aged 6 months to 5 years diagnosed with latent TB. J Tuberculosis Res. 2018;6:239–250. DOI:10.4236/jtr.2018.64022.
   Google Scholar
• Agasa B, Bosunga K, Opara A, et al. Prevalence of sickle cell disease in a northeastern region of the democratic Republic of Congo: what impact on transfusion policy? British blood transfusion society. Transfus Med. 2010;20:62–65. DOI:10.1111/j.1365-3148.2009.00943.x.
   PubMed Web of Science ®Google Scholar
• Kasai ET, Opara JPA, Agasa SB, et al. Acceptabilité du Dépistage néonatal de la drépanocytose au cours de la Pandémie au COVID-19 à Kisangani, en République Démocratique du Congo. Pan African Journal of Medicine. 2020;37:299. DOI:10.11604/pamj.2020.37.299.26654.
   PubMedGoogle Scholar
• Kasai ET, Boemer F, Djang’eing’a RM, et al. Systematic screening of Neo- natal sickle cell disease with HemoTypeSCTM Kit-test: case study and literature review. Open Journal of Blood Diseases. 2020;10:12–21. DOI:10.4236/ojbd.2020.101002.
   Google Scholar
• Neema-UfoyMungu Y, Juakali-Sihalikyolo JJ, Djang’eing’a RM, et al. Performance of sickle SCAN® in the screening of sickle cell disease in Kisangani pregnant women and attitude towards results. Open J Blood Dis. 2020;10:23–36. DOI:10.4236/ojbd.2020.102003.
   Google Scholar
• Kasai ET, Kadima JN, Opara JPA, et al. Pairing parents and offspring’s HemoTypeSC test to validate results and confirm sickle cell pedigree: case study in Kisangani, Democratic Republic of the Congo. Hematology. 2022;27(1):853–859. DOI:10.1080/16078454.2022.2107351.
   PubMed Web of Science ®Google Scholar
• Christopher H, Josephat E, Kaywanga F, et al. Potential of point of care tests for newborn screening for sickle cell disease: evaluation of HemotypeSC™ and sickle SCAN® in Tanzania. Int J Lab Hematol. 2022;44:959–965. DOI: 10.1111/ijlh.13929.
   PubMed Web of Science ®Google Scholar
• Olatunya OS, Albuquerque DM, Fagbamigbe AF, et al. Diagnostic accuracy of HemoTypeSC as a point-of-care testing device for sickle cell disease: findings from a southwestern State in Nigeria and implications for patient care in resource poor settings of sub-Saharan Africa. Global Pediatric Health. 2021;8:1–10. DOI:10.1177/2333794X211016789.
   Google Scholar
• Mukherjee MB, Colah RB, Mehta PR, et al. Multicenter evaluation of HemoTypeSC as a point-of-care sickle cell disease rapid diagnostic test for newborns and adults across India. Am J Clin Pathol. 2020;153(1):82–87. DOI:10.1093/ajcp/aqz108.
   PubMed Web of Science ®Google Scholar
• Boemer F, Cornet Y, Libioulle C, et al. 3-years’experience review of neonatal screening for hemoglobin disorders using tandem mass spectrometry. Clin Chim Acta. 2011;412(2011):1476–1479. DOI:10.1016/j.cca.2011.04.031.
   PubMedGoogle Scholar
• Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31–S34. DOI:10.4103/sja.SJA_543_18.
   PubMed Web of Science ®Google Scholar
• Pare NI. Problématique du dépistage néonatal de la drépanocytose dans la ville de Kayes au Mali [Thèse]. Bamako: Université de Bamako-Faculté de Médecine et d’odontologie; 2021. [cited 2023 Feb 28]. Available at: https://bibliosante.ml.handle.
   Google Scholar
• Shongo MYP, Mukuku O. Dépistage néonatal de la drépanocytose à Lubumbashi, République Démocratique du Congo. Rev L’Infirmier Congol. 2018;2:62–63.
   Google Scholar
• Kanyunyu J. Ebola en RDC: les raisons de la méfiance face au vaccin. Consulté le 06 octobre 2020. [cited 2023 Feb 28]. Available at https://www.dw.com/fr/ebola-en-rdc-les-raisons-de-la-m%C3%A9fiance-face-au-vaccin/a-49902768.
   Google Scholar
• Singa VB, Lungela SB. Facteurs déterminants les accouchements à domiciles dans la zone de sante de yahisuli, R. D. Congo « Risque et prévention ». IJRDO - J Health Sci Nursing. 2019;4(10):42–57.
   Google Scholar
• McGann PT. Time to invest in sickle cell anemia as a global health priority. Pediatrics. 2016;137(6):e20160348. DOI:10.1542/peds.2016-0348.
   PubMed Web of Science ®Google Scholar
• Tshilolo L, Aissi LM, Lukusa D, et al. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. J Clin Pathol. 2009;62:35–38. DOI:10.1136/jcp.2008.058958.
   PubMed Web of Science ®Google Scholar
• Nankanja R, Kadhumbula S, Tagoola A, et al. HemoTypeSC demonstrates >99% field accuracy in a sickle cell disease screening initiative in children of southeastern Uganda. Am J Hematol. 2019;94:E164–E166.
   PubMed Web of Science ®Google Scholar
• Ambrose EE, Makani J, Chami N, et al. High birth prevalence of sickle cell disease in Northwestern Tanzania. Pediatr Blood Cancer. 2018;65(1). DOI:10.1002/pbc.26735.
   PubMed Web of Science ®Google Scholar
• Elgueroa E, Délicat-Loembeta LM, Rougerona V, et al. Malaria continues to select for sickle cell trait in Central Africa. Proc Natl Acad Sci. 2015;12(22):7051–7054.
   Google Scholar
• Likwela DL. Les généralités sur le Paludisme. [Thèse]. Kisangani: Université de Kisangani-Faculté de Médecine et de Pharmacie; 2011. Available at file:///C:/Users/utilisateur/Downloads/07Premierepartie.pdf consulté le 11/01/2022.
   Google Scholar